???pagination.result.count???
???pagination.result.page???
1
A loss-of-function mutation in KCNJ11 causing sulfonylurea-sensitive diabetes in early adult life. , Vedovato N., Diabetologia. May 1, 2024; 67 (5): 940-951.
Beneficial actions of the [A14K] analog of the frog skin peptide PGLa-AM1 in mice with obesity and degenerative diabetes: A mechanistic study. , Musale V., Peptides. February 1, 2021; 136 170472.
Permanent neonatal diabetes: combining sulfonylureas with insulin may be an effective treatment. , Misra S., Diabet Med. June 13, 2018;
Distinct action of the α-glucosidase inhibitor miglitol on SGLT3, enteroendocrine cells, and GLP1 secretion. , Lee EY ., J Endocrinol. March 1, 2015; 224 (3): 205-14.
Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies. , Pörksen S., BMC Endocr Disord. September 23, 2010; 10 16.
Targeting hypertension with a new adenosine triphosphate-sensitive potassium channel opener iptakalim. , Pan Z., J Cardiovasc Pharmacol. September 1, 2010; 56 (3): 215-28.
Open state destabilization by ATP occupancy is mechanism speeding burst exit underlying KATP channel inhibition by ATP. , Li L., J Gen Physiol. January 1, 2002; 119 (1): 105-16.
Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor. , Tucker SJ., Nature. May 8, 1997; 387 (6629): 179-83.